Pharmacovigilance and pediatrics people get together at EMA to better tackle safety concerns
This article was originally published in SRA
Executive Summary
A new joint working group comprising members of the European Medicines Agency's pharmacovigilance (PRAC) and pediatric committees (PDCO) has been created to exchange information and expertise on pediatric safety issues at both committees and to share experience or provide insights on the therapeutic context of issues under discussion.
You may also be interested in...
Canada Proposes 14 New Entries To List Of Recognized Device Standards
The Canadian medtech regulator has recommended updating its list of recognized medical device standards that manufacturers can rely on to demonstrate compliance with local safety, effectiveness and labeling requirements.
Norway COVID-19 Vaccine Deaths Draw Global Attention
Reports from Norway about deaths in very frail, elderly patients soon after receiving Pfizer/BioNTech’s COVID-19 jab have drawn regulatory scrutiny. While the European Medicines Agency has launched an investigation, Australia is examining the need for specific warnings about risks of vaccination in the very frail elderly or terminally ill patients.
COVID-19 Vaccine Dosing: Pharma Says Follow The Science As It Gathers Data
The UK’s deployment of COVID-19 vaccines has left vaccine manufacturers worried about emerging discussions on dosing strategies that may not be supported by authorized labeling or published clinical data.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: